BOT 5.26% 36.0¢ botanix pharmaceuticals ltd

Ann: Trading Halt, page-14

  1. 4,735 Posts.
    lightbulb Created with Sketch. 331
    I disagree

    The CR price was probably worked out a little while ago.

    I think the spectre of funding issues over them has actually been keeping a cap on the run that could have happened.

    If a reasonable price, BOT and its share price will benefit greatly from the CR.

    Milesy
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.